EDTUTC-4 New YorkLog in Sign up

MSLE
Satellos Bioscience Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:43 PM EDT

8.42USD-1.405%(-0.12)27,669

Pre-marketOct 5, 2026 8:33:30 AM EDT

8.32USD-1.188%(-0.10)

MSLE News

Day breaks

08:26 AM EDTSatellos Granted Composition of Matter Patent for Forazapadin ·

BNN Bloomberg

07:03 AM EDTSatellos Granted Composition of Matter Patent for Forazapadin ·

Financial Post

07:00 AM EDTSatellos Granted Composition of Matter Patent for Forazapadin ·

GlobeNewswire Inc.

07:03 AM EDTSatellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy ·

Financial Post

07:00 AM EDTSatellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy ·

GlobeNewswire Inc.

07:00 AM EDTSatellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development ·

GlobeNewswire Inc.

07:00 AM EDTSatellos to Present at the 31st Annual Congress of the World Muscle Society ·

GlobeNewswire Inc.